Pages

▼
Friday, May 16, 2025

Diamyd’s GABA-Based Remygen® Unsuccessful in Phase 1 Clinical Trial

›
This clinical trial tested whether long-term daily treatment with Remygen®, an oral drug developed by Diamyd Medical, could help restore ins...
Thursday, May 8, 2025

Changes to My Blogging: AI

›
I'm going to start using generative AI (what people call "chatbot" technology) to help me create draft blog postings.    In al...
1 comment:
Thursday, April 24, 2025

Sana Biotechnology Reports First Results For Islet Transplants Without Immunosuppression

›
This blog post reports on some news that I consider exciting, for at least two different reasons: first because it might be an early milesto...
4 comments:
Tuesday, March 18, 2025

TIXIMED Starts a Phase 1 Study of TIX100

›
TIX100 is a protein which inhibits the action of TIXNP (thioredoxin-interacting protein).  It is being developed by the TIXIMED company.  TX...
1 comment:
Friday, March 7, 2025

Combination of Harmine and GLP-1RA Completes Phase-I Clinical Trial (In Healthy People)

›
This is the most fun I have had writing a blog in a long time.  It is not often I can blog about psychedelics and curing type-1 diabetes at ...
6 comments:
Friday, January 31, 2025

Denosumab Starts A Phase-I Trial In People With Established T1D

›
Denosumab is a monoclonal antibody, which is already approved for several bone related diseases and is sold under the names Wyost, Xgeva, Pr...
1 comment:
Sunday, January 19, 2025

What To Watch In 2025

›
Last year, at the start of the year, I published a blog of four research projects I was looking forward to updates in the new year.  This ye...